Schinzari, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 2.129
EU - Europa 1.979
AS - Asia 970
SA - Sud America 156
AF - Africa 44
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.295
Nazione #
US - Stati Uniti d'America 2.099
DE - Germania 513
SE - Svezia 482
SG - Singapore 347
IT - Italia 323
CN - Cina 290
BR - Brasile 141
IN - India 124
FR - Francia 123
IE - Irlanda 115
GB - Regno Unito 72
ID - Indonesia 72
UA - Ucraina 69
FI - Finlandia 63
PL - Polonia 54
RU - Federazione Russa 44
CI - Costa d'Avorio 38
TR - Turchia 30
BE - Belgio 23
KR - Corea 23
CA - Canada 20
HK - Hong Kong 19
AT - Austria 16
IR - Iran 16
CZ - Repubblica Ceca 13
AU - Australia 12
NL - Olanda 12
RO - Romania 12
ES - Italia 10
JP - Giappone 7
CH - Svizzera 6
MX - Messico 6
VN - Vietnam 6
CO - Colombia 4
GR - Grecia 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
LV - Lettonia 4
PE - Perù 4
AZ - Azerbaigian 3
CY - Cipro 3
EU - Europa 3
HR - Croazia 3
IL - Israele 3
IQ - Iraq 3
NO - Norvegia 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BD - Bangladesh 2
BG - Bulgaria 2
EC - Ecuador 2
JO - Giordania 2
LU - Lussemburgo 2
MA - Marocco 2
PA - Panama 2
PH - Filippine 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 5.295
Città #
Chandler 481
Singapore 248
Ashburn 153
Dublin 115
New York 89
Jakarta 72
Hyderabad 70
Wilmington 66
San Mateo 63
Rome 60
Fairfield 56
Ann Arbor 55
Warsaw 53
Milan 47
Princeton 46
Nanjing 44
Jacksonville 42
Helsinki 41
Boston 39
Marseille 39
Abidjan 38
Los Angeles 37
Dearborn 35
Cattolica 33
North Bergen 33
Frankfurt am Main 31
Moscow 31
The Dalles 29
Beijing 28
Seattle 28
Redwood City 26
Nürnberg 25
Woodbridge 25
Cambridge 24
Redmond 24
Brussels 23
Hefei 23
Seoul 22
Bremen 20
Houston 20
Falkenstein 18
Munich 18
Nuremberg 18
Boardman 17
Izmir 17
London 17
Nanchang 17
Hong Kong 16
Shanghai 16
Chicago 15
Falls Church 14
Hebei 12
São Paulo 12
Augusta 11
Norwalk 11
Changsha 10
Düsseldorf 10
Lawrence 10
Leawood 10
Vienna 9
Washington 9
Lauterbourg 8
Paris 8
Santa Clara 8
Brno 7
Kish 7
Mountain View 7
Naples 7
Ottawa 7
Guangzhou 6
Jiaxing 6
Kunming 6
Rio de Janeiro 6
San Francisco 6
Shenyang 6
Andover 5
Bari 5
Belo Horizonte 5
Columbus 5
Edinburgh 5
Fremont 5
Hangzhou 5
Lappeenranta 5
Mexico City 5
Miami 5
Pune 5
San Diego 5
Sydney 5
Tokyo 5
Toronto 5
Amsterdam 4
Des Moines 4
Lima 4
Madrid 4
Mumbai 4
Piacenza 4
Prague 4
Ribeirão Preto 4
Sant'Elpidio a Mare 4
University Park 4
Totale 2.931
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 282
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 189
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 138
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 137
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 136
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 117
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 116
Are TKIs favourable for the elderly with non-small-cell lung cancer? 114
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 110
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 108
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 102
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 101
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 91
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 91
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 90
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 90
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 89
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 84
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 82
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 81
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 80
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 80
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 75
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 74
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 73
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 73
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 72
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 72
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 72
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 70
Skin cancer triage and management during COVID-19 pandemic. 69
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 68
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 68
Methylation study of the Paris system for reporting urinary (TPS) categories 67
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 67
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 66
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 66
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 65
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 65
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 64
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 63
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 62
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 62
Biomarkers of response to advanced prostate cancer therapy 62
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 61
Efficacy of immune checkpoint inhibitors in different types of melanoma 61
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 61
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 59
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 58
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 57
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 55
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 54
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 53
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 53
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 52
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 51
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 47
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy 47
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 46
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 45
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 40
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 40
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 39
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 39
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 38
Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. 37
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 32
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 32
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 32
Targeted therapy in advanced gastric carcinoma: The future is beginning 30
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 28
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 25
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 23
Atypical Presentation of Splenic Tissue Mimicking Neuroendocrine Tumor Relapse 22
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 20
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer 16
A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients 15
Is 18F-fluorodeoxyglucose the tracer of choice for functional imaging of neuroendocrine tumors grade 3? A case report 14
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study 13
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis 7
Totale 5.405
Categoria #
all - tutte 29.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.485


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202089 0 0 0 0 0 0 0 0 0 0 70 19
2020/2021246 10 19 8 15 30 9 33 9 31 28 50 4
2021/2022636 59 18 15 99 39 14 13 86 33 43 95 122
2022/20231.381 181 178 100 226 57 158 103 121 143 32 59 23
2023/2024762 35 169 47 41 31 111 52 33 14 34 106 89
2024/20251.325 35 54 124 70 144 71 70 59 232 210 256 0
Totale 5.405